Evidence map›Paper›PMID 40915358›Full record

ArticleJournal of the American Academy of Dermatology2026

Five-year follow-up on randomized controlled trial of fractionated laser resurfacing as prophylaxis against actinic neoplasia.

Dan F Spandau, Ericson Torralba, Christopher Howard, Christina Knisely, Craig A Rohan, Matthew J Turner, Jade Bryant, Rita Kamoua, Jeffrey B Travers

Abstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dan F SpandauDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana.
Ericson TorralbaDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
Christopher HowardDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
Christina KniselyDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
Craig A RohanDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Medicine, Dayton Veterans Affairs Medical Center, Dayton, Ohio.
Matthew J TurnerDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
Jade BryantDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
Rita KamouaDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio.
Jeffrey B TraversDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Medicine, Dayton Veterans Affairs Medical Center, Dayton, Ohio. Electronic address: jeffrey.travers@wright.edu.

Funding

Wounding Therapy and PhotocarcinogenesisR01AG048946 · NIA · WRIGHT STATE UNIVERSITY · PI SPANDAU, DAN F, TRAVERS, JEFFREY B. · 2014 to 2024
$2.9M
Mechanisms of photocarcinogenesis in geriatric skinR01ES020866 · NIEHS · INDIANA UNIVERSITY INDIANAPOLIS · PI SPANDAU, DAN F, TRAVERS, JEFFREY B. · 2012 to 2016
$1.7M
CSRD VA I01 CX000809CSRD VA I01 CX001904CSRD VA I01 CX001956NIA NIH HHS R01 AG048946NIEHS NIH HHS R01 ES020866
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

actinic keratosislaser therapyprophylaxisskin cancer

Identifiers

PMID40915358
PMCPMC13289720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.